Search

Your search keyword '"Grassano, M"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Grassano, M" Remove constraint Author: "Grassano, M"
95 results on '"Grassano, M"'

Search Results

2. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

3. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

4. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

5. Theme 10 - Disease Stratification and Phenotyping of Patients.

6. Theme 02 - Genetics and Genomics.

7. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR

8. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

9. Brain Metabolic Correlates of Apathy in Amyotrophic Lateral Sclerosis: a 18F-FDG-PET study

11. Theme 02 - GENETICS AND GENOMICS.

12. Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort

13. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

16. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

17. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

18. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

19. Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud

20. Intermediate HTT CAG repeats worsen disease severity in amyotrophic lateral sclerosis.

21. Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis.

22. Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis.

23. High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants.

24. Hereditary motor sensory neuropathy with proximal involvement (HMSN-P) associated with TFG p.Pro285Leu variant in an Italian family with a motor neuron disease-like clinical picture.

25. Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis.

26. Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant.

27. Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS).

28. High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis.

29. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes.

30. Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries.

31. The role of peripheral immunity in ALS: a population-based study.

32. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis.

33. Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis.

34. Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients.

35. Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions.

36. Factors predicting disease progression in C9ORF72 ALS patients.

37. Role of brain 2-[ 18 F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis.

38. Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[ 18 F]FDG-PET study.

39. Integrative genetic analysis illuminates ALS heritability and identifies risk genes.

40. Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis.

41. Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis.

42. Brain 18 fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations.

43. Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats.

44. Can amyotrophic lateral sclerosis progression really pause? A cohort study using the medical research council scale.

45. Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross-sectional population-based study.

46. Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers.

47. Systematic evaluation of genetic mutations in ALS: a population-based study.

48. Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants.

49. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes.

50. What is amyotrophic lateral sclerosis prevalence?

Catalog

Books, media, physical & digital resources